Platelet-to-Albumin Ratio: The Prognostic Utility in the Prediction of 2-Month Postoperative Heart Transplant Complications

Author:

Baba Dragos-Florin12ORCID,Suciu Horatiu13,Huma Laurentiu12ORCID,Avram Calin4ORCID,Danilesco Alina2,Moldovan Diana Andreea1,Opincar Andrei Stefan5,Sin Anca Ileana2

Affiliation:

1. Emergency Institute for Cardiovascular Diseases and Transplantation, 540142 Targu Mures, Romania

2. Department of Cell and Molecular Biology, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Târgu Mures, 540142 Targu Mures, Romania

3. Department of Surgery, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Târgu Mures, 540142 Targu Mures, Romania

4. Department of Medical Informatics and Biostatistics, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Târgu Mures, 540142 Targu Mures, Romania

5. Faculty of Medicine, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Târgu Mures, 540142 Targu Mures, Romania

Abstract

Background: The platelet-to-albumin ratio (PAR), leucocyte-to-albumin ratio (LAR), neutrophil percentage-to-albumin ratio (NPAR), and monocyte-to-albumin ratio (MAR) represent easily reproducible markers, which may predict the outcomes in various diseases. Early postoperative complications might appear after heart transplantation, such as infections, diabetes mellitus type 2 (DM2), acute graft rejection, and atrial fibrillation (AFib). Objective: The aim of our study was to investigate the PAR, LAR, NPAR, and MAR values before and after heart transplantation, and the associations of the preoperative levels of these markers with the presence of postoperative complications in first two months after surgery. Methods: Our retrospective research was directed from May 2014 to January 2021, with a total number of 38 patients being included. We used cut-off values for the ratios from previously published studies, as well as our own determination of these levels by using a receiver operating characteristic (ROC) curve. Results: By ROC analysis, the optimal preoperative PAR cut-off value was 38.84 (AUC: 0.771, p = 0.0039), with 83.3% sensitivity, and 75.0% specificity. Applying a Chi square (χ2) test, PAR > 38.84 represented an independent risk factor for complications, regardless of cause, and postoperative infections. Conclusions: Preoperative PAR > 38.84 was a risk factor of developing complications of any cause, and postoperative infections in the first two months after heart transplantation.

Funder

This research was funded by the University of Medicine, Pharmacy, Science, and Technology “George Emil Palade” of Târgu Mures

Publisher

MDPI AG

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics

Reference44 articles.

1. The first human heart transplant and further advances in cardiac transplantation at Groote Schuur Hospital and the University of Cape Town—With reference to: The operation. A human cardiac transplant: An interim report of a successful operation performed at Groote Schuur Hospital, Cape Town;Brink;Cardiovasc. J. Afr.,2009

2. Complications after Heart Transplantation: Hope for the Best, but Prepare for the Worst;Alba;Int. J. Organ Transplant. Med.,2016

3. The international society of heart and lung transplantation guidelines for the care of heart transplant recipients;Costanzo;J. Heart Lung Transplant.,2010

4. Plasma cytokine parameters and mortality in patients with chronic heart failure;Rauchhaus;Circulation,2000

5. Role of Inflammation in Heart Failure;Shirazi;Curr. Atheroscler. Rep.,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3